Other

• Other

‘Seismic shift’ as obesity overtakes cancer for R&D returns

pharminent May 5, 2026

• Other

223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease

pharminent May 4, 2026

• Other

FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech

pharminent April 29, 2026

• Other

Seaport and Hemab target $180m IPOs as biotech listings accumulate

pharminent April 28, 2026

• Other

GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio

pharminent April 27, 2026

• Other

New NIHR-funded TRC for Parkinson’s disease

pharminent April 27, 2026

• Other

UK biotech could be bound for recovery, BIA report reveals

pharminent April 27, 2026

• Other

MSD teams up with Google Cloud on agentic AI transformation

pharminent April 23, 2026

• Other

Neurology, biomanufacturing start-ups bag UK AI funding

pharminent April 22, 2026

• Other

221: An Interview With Dutch Neurologist Ewout Groen of SMA Europe

pharminent April 20, 2026

• Other

AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle

pharminent April 20, 2026

• Other

Boehringer Ingelheim launches AI centre in London

pharminent April 20, 2026

• Other

S16 Ep55: OncoBytes Adaptive Learning Pathways: Personalizing Treatment Plans to Optimize Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

pharminent April 20, 2026

• Other

UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator

pharminent April 20, 2026

• Other

What actually drives speed in complex drug development programs

pharminent April 20, 2026

• Other

S16 Ep53: Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck – Post-CRT Decisions in the Locally Advanced Setting

pharminent April 17, 2026

• Other

OpenAI introduces GPT-Rosalind, its drug discovery AI

pharminent April 17, 2026

• Other

The innovators working to make in vivo cell therapy a reality

pharminent April 17, 2026

• Other

Amazon launches its AI drug discovery platform

pharminent April 15, 2026

• Other

Amazon launches AI drug discovery platform

pharminent April 15, 2026

• Other

Novo Nordisk and OpenAI forge alliance to drive speedy drug development

pharminent April 14, 2026

• Other

220: An Interview With Dr. Jaime Moore on Obesity Medications and Neuromuscular Disease

pharminent April 13, 2026

• Other

Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers

pharminent April 10, 2026

• Other

Pulmonary fibrosis drug developer Avalyn files IPO

pharminent April 9, 2026

• Other

Avalyn plots IPO to push inhaled pulmonary fibrosis pipeline through clinic

pharminent April 9, 2026

• Other

219: An Interview With Dr. Natalie Truba on the Psychological Aspects of Gene Therapy

pharminent April 7, 2026

• Other

Aspect Biosystems receives funding for cellular medicine project

pharminent April 6, 2026

• Other

Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26

pharminent April 2, 2026

• Other

S16 Ep42: Variability and Innovation in Small Cell Lung Cancer Care: With Ticiana Leal, MD

pharminent March 31, 2026

• Other

Drug Channels News Roundup, March 2026: Cigna’s 340B Workaround, Merck’s ARPA Surprise, Walgreens’ Automation Bet, Why Rebates Hurt Patients, and a DCI Team Photo

pharminent March 31, 2026

• Other

Biotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026

pharminent March 31, 2026

• Other

One in four diabetics has undiagnosed heart failure; study

pharminent March 30, 2026

• Other

Trustworthy AI in clinical oversight

pharminent March 30, 2026

• Other

S16 Ep38: Live Tumor Board: Precision Pathways Transforming Patient Care in Advanced NSCLC

pharminent March 27, 2026

• Other

NOW AVAILABLE: The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

pharminent March 24, 2026